The goal of the Section on Psychosis is to improve the lives of people with psychotic illnesses (including schizophrenia and schizoaffective disorder) through a multi-disciplinary program that includes research, education, and clinical care.   We are convinced that the care of individuals with these illnesses should be guided by the best evidence from research.  Since psychotic illnesses are caused by disordered functioning of the brain, we also believe that research focused on the brain will lead to better treatments.

Clinical research programs in the Section on Psychosis are available for a broad range of individuals including patients who are at high risk for schizophrenia or schizoaffective disorder and those with early signs, patients recently diagnosed with these illnesses, and patients who have lived with these illnesses for years.   

Director: 
Stephen Marder